Pharma Focus America

LATEST NEWSRead more...

17

Jul 2024

SOTIO and Biocytogen Announce Collaboration to Expand ADC Development with Multi-Target Antibody Agreement

SOTIO Biotech a clinicalstage biopharmaceutical company under PPF Group and Biocytogen a global biotechnology firm listed on the Hong Kong Stock Exchange have entered into a research collaboration

17

Jul 2024

SPI Pharma and Inimmune Corp. Partner to Create Innovative Vaccine Adjuvant Systems

SPI Pharma Inc and Inimmune Corp have entered into a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development This partnership

17

Jul 2024

DiscGenics Receives FDA Approval for Phase III Clinical Trial of Injectable Cell Therapy for Lumbar Degenerative Disc Disease

DiscGenics Inc a biopharmaceutical company specializing in cellbased regenerative therapies for musculoskeletal degeneration has gained FDA acceptance for its Phase III clinical protocols and Chemistry

16

Jul 2024

AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Reach Milestone in Advancing Biomarkers for Alzheimer’s Disease and Neurodegeneration

Fujirebio Holdings Inc and its subsidiary Fujirebio Diagnostics Inc have announced a significant achievement in their strategic partnership with AriBio Co Ltd This collaboration focuses on advancing

16

Jul 2024

Integrated DNA Technologies Enters New Licensing Agreement with SeQure Dx to Propel CRISPR-based Therapeutic Development

Integrated DNA Technologies a global leader in CRISPR genome editing solutions has partnered with SeQure Dx a company specializing in offtarget analysis for gene modification in preclinical and clinical

16

Jul 2024

INCOG BioPharma Intensifies Plans for Expansion

INCOG BioPharma Services a prominent contract development and manufacturing organization specializing in sterile injectable biopharmaceuticals has announced a significant expansion of its manufacturing capabilities The company plans to commence construction

press releasesRead more...

Orum Therapeutics Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of Orum’s TPD²® Technology to Develop Novel Degrader-Antibody Conjugates

Orum Therapeutics a clinicalstage private biotechnology company pioneering the field of degraderantibody conjugates today announced a global multitarget license

Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap

Annovis Bio Inc a latestage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimers Disease and Parkinsons Disease announced today that it has received approval

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

ANI Pharmaceuticals Inc today announced that following final approval from the US Food and Drug Administration for its Abbreviated New Drug Application the Company launched LGlutamine Oral Powder ANIs LGlutamine Oral

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

Artelo Biosciences Inc a clinicalstage pharmaceutical company focused on modulating lipidsignaling pathways to develop treatments for people living

18 - 20

Jul 2024

Pharma India Expo 2024

Telangana, India

29 - 31

Jul 2024

29 - 31

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

15 - 16

Aug 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific - mRNA Services
Future Labs Live USA 2024
World Vaccine Congress Europe 2024
World Orphan Drug Congress 2024
Advanced Therapies USA 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    Data Analytics and Forecasting in Pharmaceutical Distribution

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    Addressing the Opioid Crisis: The Role of Pharmaceutical Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    The Future of Pharma: Integrating Imaging Informatics for Better Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Innovative Technologies Driving Vaccine Research and Production: A Revolution in Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues